by NMS | Oct 9, 2023 | 2023, Events, News
We are attending the 2023 BIO Europe partnering event in Munich, Germany. NMS Group- Nerviano Medical Sciences will participate to the 2023 BIO Europe partnering event, which will be held in Munich from November 6th to 8th, 2023 and online from November 14th to 15th,...
by NMS | Oct 2, 2023 | 2023, Events, News
NERVIANO, IT and BOSTON, Mass, October 2, 2023 – Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group) and Nerviano Medical Sciences, Inc., a wholly owned subsidiary of NMS Group, focused on the discovery and early development of oncology...
by NMS | Sep 25, 2023 | 2023, Events, News
September 25th, 2023 Nerviano Medical Sciences S.r.l., a member of NMS Group S.p.A and a clinical stage biotech discovering and developing innovative therapies for the treatment of cancer, is proud to announce its participation to the World ADC 2023 summit that will...
by NMS | Sep 21, 2023 | 2023, Events, News
Nerviano Medical Sciences (NMS), una Biotech focalizzata sulla ricerca e sviluppo di farmaci Oncologici innovativi, partecipa alla Settimana Europea delle Biotecnologie (European Biotech Week – EBW), giunta quest’anno alla sua XI edizione. La EBW è una settimana...
by NMS | Aug 30, 2023 | 2023, Events, News
ACCELERA, a fully GLP and AAALAC accredited preclinical Contract Research Organization collaborating with more than 350 Sponsors in 25 countries, offers IND-enabling packages. Based on our extensive experience in having conducted more than 80 Small Molecules, Large...
by NMS | Apr 4, 2023 | 2023, Events, News
NERVIANO, 4 April 2023 – Nerviano Medical Sciences Srl (Company), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that data from the Phase I/II clinical study of...
Welcome and Check out our new motion picture!
Recent Comments